Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma. - Test2 - elhamkhani - TriplyDB

Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.

Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.

http://www.wikidata.org/entity/Q36627182

about

Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response.Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients Prognostic significance of multiple kallikreins in high-grade astrocytoma.Kallikreins - The melting pot of activity and function Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer.Kallikrein-related peptidases (KLKs) and the hallmarks of cancer.The brain tissue response to surgical injury and its possible contribution to glioma recurrence.Thrombin Activity and Thrombin Receptor in Rat Glioblastoma Model: Possible Markers and Targets for Intervention?Expression of Kallikrein-Related Peptidase 6 in Primary Mucosal Malignant Melanoma of the Head and Neck.Targeting the thrombin receptor modulates inflammation and astrogliosis to improve recovery after spinal cord injury Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases.Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion.The Thrombin Receptor Restricts Subventricular Zone Neural Stem Cell Expansion and Differentiation.Kallikrein-related peptidase 6 orchestrates astrocyte form and function through proteinase activated receptor-dependent mechanisms

P2860

Q33581581-4B9DF8BB-B730-42D8-A1C5-A5192B3BA7B6 Q33898338-D7D1C52E-82EF-4EDD-9430-4833F08D5D68 Q33898347-58DBA7A2-AEED-40BE-A0E0-C5704B43DC41 Q34087004-750E9BA4-FA7D-4257-8128-0C935FB03A9B Q35623800-A959C917-B960-432B-B9DC-77CEB4743146 Q35732225-39F24AC8-CEBB-4508-B11E-D862AF83F6B0 Q36563056-45CFB032-68C6-4B71-92F3-D45686F0E4CD Q37709144-F3CBB006-F113-43A5-AA91-73F8CD934AF8 Q38737293-A16AAD4E-F51D-40CB-8D0E-2E54B618ADD5 Q38767957-9E94ED61-F39A-4F95-897D-0930D142C320 Q38908560-38F41F8E-4B03-4210-A577-3649B01918F1 Q39187457-38B1FDA2-FDFE-4F11-9F96-895A069FD6A3 Q41922463-34E34E51-CC96-4887-B7A6-6F4C90336696 Q42696477-ACDDF310-B97A-4E39-8A2E-A6F4DB47FFD7 Q55338815-9082F436-73AB-4673-A156-F351D112225D Q55403496-6B8BE761-2EED-44EC-813F-319544517118 Q58699560-A0501532-CC3B-45A9-907A-44B2ADBD0AFC

P2860

Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.

http://www.wikidata.org/entity/Q36627182

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.

@ast

Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.

@en

type

label

Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.

@ast

Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.

@en

prefLabel

Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.

@ast

Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.

@en

P1433

Q36627182-3AA08572-DDAD-48D2-B010-B2937B387BF1

P1476

Q36627182-EA7C020C-412F-42DD-9EEF-836C1144CCA8

P2093

Q36627182-198F94E6-58B7-4990-8062-40E159DF7DDE

Q36627182-23DC1EE6-01E0-4E55-AB01-62B45F43F2D3

Q36627182-2F903542-8711-4878-9D26-27BF9505A27F

Q36627182-80B5E2E1-9FB3-4C3E-B59E-8991E798D680

Q36627182-98638EBF-D15A-448F-B9E4-AF3594AA1EE2

Q36627182-AEA60557-8FFF-4548-98F3-5B8A6B9E19FC

Q36627182-B2405B43-2F78-48EA-A916-BC72188512FF

Q36627182-B5ADA9B2-4C67-4BF2-B22B-724AB35F74A2

Q36627182-C90C0534-AA40-44C0-8935-A88B03C120B9

Q36627182-D7A1E849-28C8-4067-AF49-844378AD9632

P2860

Q36627182-05EEF83C-4BE1-47BD-A677-D2477FDC359D

Q36627182-0A8A90D3-6D40-4B29-BCE3-FF882A455233

Q36627182-12F672B6-5DAE-4D6E-82D8-C4223AF753F5

Q36627182-135F09C4-E471-452C-97A1-3EF94CDAC298

Q36627182-15CE7F14-AB20-4DD3-9773-0C5FB386FD59

Q36627182-16CF0B6B-F411-443F-B572-D8877D172667

Q36627182-1B1A4CDA-FC60-4CBE-91B5-A7B916B8602E

Q36627182-20B41681-4294-4892-B54F-E116445995D7

Q36627182-25A24A0E-F2A1-4B2E-A605-34A10F79CF12

Q36627182-27B7B3F2-9301-4F29-B470-0D77800817CE

P304

Q36627182-95D698F6-3F09-42AB-8F18-4397B4537826

P31

Q36627182-74FE91AE-837E-457E-A4DA-741ECDE1F2EA

P356

Q36627182-58C29D06-393E-4785-801E-90495494E788

P433

Q36627182-F479E748-738A-42F6-AF8C-34BFA6333822

P478

Q36627182-1D7A0D96-8199-412D-94C3-94ED899AC7A3

P577

Q36627182-A12958CA-F4FB-4C90-B0D3-67AA10607505

P698

Q36627182-D59281B8-4E8B-4EA3-A2F0-AE14180F2B24

P932

Q36627182-C15F6666-CA5A-4D16-8AFB-5420964D9D6B

P356

P1433

P1476

Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.

@en

P2093

Alex R Paulsen

http://www.w3.org/2001/XMLSchema#string

Brian P O'Neill

http://www.w3.org/2001/XMLSchema#string

Caterina Giannini

http://www.w3.org/2001/XMLSchema#string

Isobel A Scarisbrick

http://www.w3.org/2001/XMLSchema#string

Joon H Uhm

http://www.w3.org/2001/XMLSchema#string

Kristen L Drucker

http://www.w3.org/2001/XMLSchema#string

Michael Blaber

http://www.w3.org/2001/XMLSchema#string

Paul A Decker

http://www.w3.org/2001/XMLSchema#string

Robert B Jenkins

http://www.w3.org/2001/XMLSchema#string

Sachiko I Blaber

http://www.w3.org/2001/XMLSchema#string

P2860

Proteinase-activated receptors, targets for kallikrein signaling

Molecular dissection of reactive astrogliosis and glial scar formation

Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Activity of a newly identified serine protease in CNS demyelination

PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism

Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis

Enzymatic properties of rat myelencephalon-specific protease

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

MSP, a trypsin-like serine protease, is abundantly expressed in the human nervous system.

P304

305-318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOS313

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23307575

http://www.w3.org/2001/XMLSchema#string

P932

3578488

http://www.w3.org/2001/XMLSchema#string